Trial Profile
Efficacy of Rifaximin for Diarrhea-predominant Irritable Bowel Syndrome With Positive Lactulose Hydrogen Breath Test
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 07 Oct 2015 New trial record